DSP-1083

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DSP-1083, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease [Phase 1, Phase 2]

See pricing